Ackerman Capital Advisors LLC bought a new position in Markel Co. (NYSE:MKL) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 305 shares of the insurance provider’s stock, valued at approximately $326,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Aevitas Wealth Management Inc. purchased a new stake in shares of Markel in the fourth quarter worth about $108,000. First Personal Financial Services boosted its position in shares of Markel by 156.1% in the fourth quarter. First Personal Financial Services now owns 105 shares of the insurance provider’s stock worth $120,000 after buying an additional 64 shares during the period. SeaCrest Wealth Management LLC purchased a new stake in shares of Markel in the fourth quarter worth about $122,000. Simplex Trading LLC boosted its position in shares of Markel by 169.1% in the fourth quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock worth $168,000 after buying an additional 93 shares during the period. Finally, Cigna Investments Inc. New purchased a new stake in shares of Markel in the fourth quarter worth about $201,000. 78.12% of the stock is owned by institutional investors.
In other Markel news, Vice Chairman Steven A. Markel sold 200 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $1,143.47, for a total transaction of $228,694.00. Following the sale, the insider now owns 106,360 shares in the company, valued at $121,619,469.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Alan I. Kirshner sold 100 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $1,133.50, for a total value of $113,350.00. The disclosure for this sale can be found here. Insiders sold 1,800 shares of company stock valued at $2,001,120 in the last three months. 2.53% of the stock is currently owned by company insiders.
Markel Co. (NYSE MKL) opened at $1,155.60 on Friday. The company has a market capitalization of $16,432.67, a PE ratio of 44.83 and a beta of 0.95. Markel Co. has a 1-year low of $936.95 and a 1-year high of $1,194.98. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.33.
Markel (NYSE:MKL) last issued its quarterly earnings results on Tuesday, February 6th. The insurance provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $8.55 by ($1.91). The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Markel had a net margin of 6.52% and a return on equity of 0.39%. equities analysts forecast that Markel Co. will post 33.19 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://stocknewstimes.com/2018/03/23/ackerman-capital-advisors-llc-buys-new-stake-in-markel-co-mkl.html.
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.